Gatiflox (gatifloxacin) / Orient Europharma 
Welcome,         Profile    Billing    Logout  

2 Trials

   

Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Gatiflox (gatifloxacin) / Orient Europharma
ChiCTR-TRC-12002693: Comparative Study of Human Aqueous Humor Levels of Gatifloxacin 0.3% Eye Gel, Gatifloxacin 0.3% and Levofloxacin 0.5% Ophthalmic Solution after Topical Dosing

Completed
4
150
 
One drop of gatifloxacin 0.3% eye gel was administration ;One drop of gatifloxacin 0.3% ophthalmic solution ;One drop of levofloxacin 0.5% ophthalmic solution
Zhejiang University; Zhejiang University, Zhejiang Key Innovation Team Project of China (2009R50039); Zhejiang Key Laboratory Fund of China (2011E10006)
endoophthalmitis after cataract surgery
 
 
NCT03625739: Population Pharmacokinetics of Anti-tuberculosis Drugs in Children With Tuberculosis

Recruiting
N/A
800
RoW
anti-tuberculosis drug, Isoniazid, Rifampicin, Pyrazinamide, Ethambutol, Levofloxacin, Moxifloxacin, Gatifloxacin, Amikacin, Capreomycin, Kanamycin (Streptomycin), Ethionamide, Cycloserine, terizidone, Clofazimine, Bedaquiline, Delamanid, p-aminosalicylic acid, Imipenem-cilastatind, Amoxicillin-clavulanate, Thioacetazone
Beijing Children's Hospital, Shandong University, Hopital Universitaire Robert-Debre, Rennes University Hospital
Tuberculosis
10/26
12/26

Download Options